Pliant Therapeutics, Inc. (PLRX)
1.16
0.00 (0.00%)
USD |
NASDAQ |
Jun 11, 15:02
Pliant Therapeutics Total Liabilities (Quarterly) : 37.43M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 37.43M |
| December 31, 2025 | 49.36M |
| September 30, 2025 | 76.29M |
| June 30, 2025 | 79.74M |
| March 31, 2025 | 87.61M |
| December 31, 2024 | 92.87M |
| September 30, 2024 | 99.84M |
| June 30, 2024 | 91.05M |
| March 31, 2024 | 84.27M |
| December 31, 2023 | 38.58M |
| September 30, 2023 | 37.42M |
| June 30, 2023 | 41.83M |
| March 31, 2023 | 35.96M |
| Date | Value |
|---|---|
| December 31, 2022 | 37.27M |
| September 30, 2022 | 40.19M |
| June 30, 2022 | 36.83M |
| March 31, 2022 | 23.23M |
| December 31, 2021 | 22.16M |
| September 30, 2021 | 13.68M |
| June 30, 2021 | 11.74M |
| March 31, 2021 | 11.08M |
| December 31, 2020 | 12.46M |
| September 30, 2020 | 11.98M |
| June 30, 2020 | 12.99M |
| March 31, 2020 | 10.50M |
| December 31, 2019 | 9.084M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 40.23M |
| CorMedix, Inc. | 378.59M |
| Eloxx Pharmaceuticals, Inc. | 16.09M |
| Cannabis Global, Inc. | 6.178M |
| BioStem Technologies, Inc. | 23.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 202.60M |
| Shareholders Equity (Quarterly) | 165.17M |
| Debt to Equity Ratio | 0.1743 |
| Current Ratio | 16.89 |
| Net Debt Paydown Yield | 8.05% |